Drug Search Results
More Filters [+]

Tetrofosmin

Alternative Names: tetrofosmin, myoview, myoview 30ml, myoview
Latest Update: 2024-12-02
Latest Update Note: News Article

Product Description

a new 99mTc-labeled myocardial perfusion imaging agent for the detection of myocardial perfusion abnormalities, with those of 201Tl and coronary angiography. (Sourced from: https://www.ahajournals.org/doi/10.1161/01.CIR.91.2.313)

Mechanisms of Action: Radioactive Agent

Novel Mechanism: No

Modality: Diagnostic Agent

Route of Administration: Injection

FDA Designation: None *

Approval Status: Approved

Approved Countries: Australia | Austria | Belgium | Bulgaria | Canada | Cyprus | Czech | Finland | France | Germany | Greece | Hong Kong | Hungary | Indonesia | Ireland | Israel | Italy | Latvia | Lithuania | Malaysia | Malta | Netherlands | Norway | Peru | Portugal | Romania | Russia | Singapore | Slovakia | Slovenia | Sweden | Switzerland | Taiwan | Turkey | United Kingdom | United States

Approved Indications: None

Known Adverse Events: None

Company: None
Company Location:
Company CEO:
Additonal Commercial Interests: None

Clinical Description

Map of Global Clinical Trials for Tetrofosmin

Countries in Clinic:

Active Clinical Trial Count:

Highest Development Phases

Trial

Phase

Trial Status

Disease

Primary Completion Date

Probability of Success

Recent News Events